ArticlePLOS mental health2026
Barriers to substance use disorder treatment among Asian Americans in New York City: A qualitative study of provider perspectives.
Article in PLOS mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Substance use disorders (SUDs) are a major mental health and public health concern in the United States, yet research and services for Asian American populations remain sparse. Although SUD prevalence among Asian Americans is not consistently higher than in other racial groups, treatment utilization is markedly lower, and the aggregation of diverse ethnic groups into a single category and the "model minority" stereotype obscure heterogeneity in needs and contribute to underdiagnosis, undertreatment, and limited culturally competent care. We conducted one-on-one, semi-structured interviews with eight healthcare and community-based providers serving Asian American clients with SUD across clinical and community settings in New York City (NYC) between December 2022 and May 2023. Participants were recruited through purposive sampling. Interviews lasted 45-60 minutes, were audio-recorded and transcribed verbatim, and were analyzed using a combined deductive-inductive thematic approach, alongside multiple researchers independently coding the data and reconciling themes through team-based discussion. Six interrelated themes emerged: types of services provided; substance use trends; barriers to care; community needs; existing interventions tailored to Asian Americans; and client engagement strategies. Providers described a wide spectrum of inpatient, outpatient, and court-mandated services, but identified pervasive shortfalls in cultural and linguistic competence. Substance use patterns differed by age, with growing ketamine use among younger clients and persistent alcohol use among older clients. Key barriers included stigma rooted in cultural beliefs about mental health, limited bilingual capacity, opaque communication from court-mandated treatment pathways, and intersecting socioeconomic pressures including housing instability and food insecurity. Providers also noted that aggregation of Asian American subgroups in data collection obscured distinct needs and impeded program planning. Findings highlight a pressing need for culturally and linguistically tailored SUD treatment, stronger collaboration between treatment programs and the legal system, sustained investment in community-based organizations, and disaggregated data collection across Asian American subgroups.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.